Integral Derivatives’s Enovis ENOV Stock Holding History

Integral Derivatives’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-63,039	Closed	-$8.09M	–	1428
2014 Q2	$8.09M	Buy	+63,039	New	+$7.87M	0.14%	108

Other funds holding ENOV

BCP

BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

ACM

AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Integral Derivatives's ENOV Position: Q3 2014 in Review

Integral Derivatives sold out of Enovis (ENOV) in Q3 2014, closing a stake of 7,263 shares — an estimated $932K sold.

Integral Derivatives first reported a position in ENOV in Q2 2014 and held it in 1 quarter. The position peaked at $932K in Q2 2014. 211 funds tracked by Wall St. Rank hold ENOV as of Q3 2014.

Integral Derivatives reported no remaining Enovis position as of Q3 2014 after selling out during the quarter.
Integral Derivatives sold 7,263 Enovis shares in Q3 2014, an estimated $932K.
Integral Derivatives first reported a position in Enovis in Q2 2014 and held it in 1 quarter.
Integral Derivatives's Enovis position peaked at $932K in Q2 2014.
211 funds tracked by Wall St. Rank held Enovis as of Q3 2014.

Based on Integral Derivatives's 13F filing for Q3 2014, filed 6 Oct 2014.